Shilpa Medicare informs about disclosure

26 Feb 2024 Evaluate

Shilpa Medicare has informed that the company, headquartered at Raichur, Karnataka, India, has received closure of Decentralized Procedure for Varenicline Tablets, 0.5 mg and 1 mg. Commercial supplies shall be started after the approval of National Procedure. Varenicline is indicated for smoking cessation in adults. It is used for quitting smoking. This product had sales of about 57 Million USD as of December 2021 prior to a decline in sales due to drug shortage due to post-production quality issues. This approval will enable Shilpa to make this quality medicine available to adults who intend to quit smoking and fill the drug shortage.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

323.95 -2.00 (-0.61%)
17-Dec-2025 14:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.90
Dr. Reddys Lab 1272.30
Cipla 1495.50
Zydus Lifesciences 917.85
Lupin 2111.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×